Finance Considers Excluding Drug Appraisals, Relying On Military Prices

By John Wilkerson / September 10, 2021 at 5:45 PM
The Senate Finance Committee is not expected to include a drug appraisal organization in its Medicare drug-price negotiation bill, and Democratic committee staff are considering incorporating a military drug discount program, called the Federal Ceiling Price, into Medicare price negotiation, lobbyists on both sides of the drug pricing debate said. One source said the committee is considering using the Federal Ceiling Price as a fallback for failed Medicare negotiations, but it’s not clear whether the fallback approach would replace an...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.